Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes:: Identification of gyrA and parC and specification of point mutations associated with resistance

被引：59

作者：

Yan, SS

Fox, ML

Holland, SM

Stock, F

Gill, VJ

Fedorko, DP

机构：

[1] NIAID, Microbiol Serv, CPD, Ctr Clin,NIH, Bethesda, MD 20892 USA

[2] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 11期

关键词：

D O I：

10.1128/AAC.44.11.3196-3198.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A strain of Streptococcus pyogenes resistant to multiple fluoroquinolones was isolated from the blood of an immunocompromised patient. Resistance to fluoroquinolones in S. pyogenes has not been previously studied. Compared to 10 sensitive strains of S. pyogenes, the fluoroquinolone-resistant clinical isolate of S, pyogenes presented point mutations in gyrA, predicting that serine-81 was changed to phenylalanine and that methionine-99 was changed to leucine, and in parC, predicting that serine-79 was changed to tyrosine. The mechanism of fluoroquinolone resistance in this isolate of S. pyogenes appears to be analogous to previously reported mechanisms for Streptococcus pneumoniae.

引用

页码：3196 / 3198

页数：3

共 18 条

[1] Molecular characterization of the gene encoding the DNA gyrase a subunit of Streptococcus pneumoniae
Balas, D
Fernández-Moreira, E
De la Campa, AG
[J]. JOURNAL OF BACTERIOLOGY, 1998, 180 (11) : 2854 - 2861
[2] A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new 'respiratory quinolones'
Blondeau, JM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 : 1 - 11
[3] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
Chen, DK
McGeer, A
de Azavedo, JC
Low, DE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) : 233 - 239
[4] Mechanism of fluoroquinolone action
Drlica, K
[J]. CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (05) : 504 - 508
[5] FERRARO MJ, 2000, NCCLS METHODS DILUTI
[6] Hyper-IgE syndrome with recurrent infections - An autosomal dominant multisystem disorder
Grimbacher, B
Holland, SM
Gallin, JI
Greenberg, F
Hill, SC
Malech, HL
Miller, JA
O'Connell, AC
Puck, JM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (09) : 692 - 702
[7] Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong
Ho, PL
Que, TL
Tsang, DNC
Ng, TK
Chow, KH
Seto, WH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1310 - 1313
[8] High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
Janoir, C
Zeller, V
Kitzis, MD
Moreau, NJ
Gutmann, L
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2760 - 2764
[9] Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
Jorgensen, JH
Weigel, LM
Ferraro, MJ
Swenson, JM
Tenover, FC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 329 - 334
[10] INVITRO ACTIVITY OF SPARFLOXACIN AND 6 REFERENCE ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA
LOUIE, A
BALTCH, AL
RITZ, WJ
SMITH, RP
[J]. CHEMOTHERAPY, 1991, 37 (04) : 275 - 282

← 1 2 →